These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 448155)
1. Studies on in vivo priming of the TNP-reactive cytotoxic effector cell system. I. Comparison of the effects of intravenous inoculation with TNP-conjugated cells on the development of contact sensitivity and cell-mediated lympholysis. Fujiwara H; Levy RB; Shearer GM; Terry WD J Immunol; 1979 Jul; 123(1):423-5. PubMed ID: 448155 [TBL] [Abstract][Full Text] [Related]
2. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression. Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397 [TBL] [Abstract][Full Text] [Related]
3. Generation of anti-hapten T cell cytotoxicity in vivo. Relationship to contact sensitivity and the role of contrasuppression. Ptak W; Friedman AM; Flood PM Arch Immunol Ther Exp (Warsz); 1994; 42(3):185-92. PubMed ID: 7487350 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers. Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049 [TBL] [Abstract][Full Text] [Related]
5. Limiting dilution analysis of induced unresponsiveness to trinitrophenyl: increased suppression of cytotoxic T precursor cells at unchanged frequencies. Cooper JM; Eichmann K J Mol Cell Immunol; 1985; 2(2):83-94. PubMed ID: 3880510 [TBL] [Abstract][Full Text] [Related]
6. Studies on in vivo priming to TNP-reactive cytotoxic effector cell system. II. Augmented secondary cytotoxic response by radioresistant T cells and demonstration of differential helper activity as a function of the stimulating dose of TNP-self. Fujiwara H; Shearer GM J Immunol; 1980 Mar; 124(3):1271-6. PubMed ID: 6965689 [No Abstract] [Full Text] [Related]
7. Genetic control of cell-mediated lympholysis to trinitrophenyl (TNP)-modified murine syngeneic cells. I. Expression of Ir gene function at the Cytotoxic precursor and helper cell levels in the response to TNP-H-2 b self. Fujiwara H; Shearer GM J Immunol; 1981 Mar; 126(3):1047-51. PubMed ID: 6780621 [No Abstract] [Full Text] [Related]
8. H2Kk can influence whether cytotoxic T lymphocytes recognize trinitrophenyl in association with H2Dk unique or H-2Kk and H-2Dk shared self determinants. Fujiwara H; Tsuchida T; Levy RB; Shearer GM J Immunol; 1982 Sep; 129(3):1189-93. PubMed ID: 6179996 [TBL] [Abstract][Full Text] [Related]
9. Detection of shared H-2Kk and H-2Dk antigens that function as self determinants for cell-mediated lympholysis to trinitrophenyl-self. Fujiwara H; Levy RB; Shearer GM J Immunol; 1981 Apr; 126(4):1522-5. PubMed ID: 6162891 [TBL] [Abstract][Full Text] [Related]
10. Split unresponsiveness to the trinitrophenyl determinant. I. Manoeuvers which suppress either humoral or cell-mediated immune responses. Ptak W; Rózycka D Eur J Immunol; 1977 Dec; 7(12):855-60. PubMed ID: 75801 [TBL] [Abstract][Full Text] [Related]
12. Cell surface expression of I-A products is required for contact sensitivity induction by trinitrophenyl-coupled epidermal cells. Ikezawa Z; Sato M; Nagai R; Okuda K Microbiol Immunol; 1981; 25(12):1335-44. PubMed ID: 6950201 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system. Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375 [TBL] [Abstract][Full Text] [Related]
14. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cells. Finberg R; Greene MI; Benacerraf B; Burakoff SJ J Immunol; 1979 Sep; 123(3):1205-9. PubMed ID: 89164 [TBL] [Abstract][Full Text] [Related]
15. Split unresponsiveness to trinitrophenyl (TNP) determinant. Suppression of anti-TNP antibody responses by sensitization with picryl chloride. Rózycka D; Ptak W Immunology; 1978 Aug; 35(2):229-35. PubMed ID: 86500 [TBL] [Abstract][Full Text] [Related]
16. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses. Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772 [TBL] [Abstract][Full Text] [Related]
17. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells. Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193 [TBL] [Abstract][Full Text] [Related]
18. Hapten specific TNP-reactive cytotoxic effector cells using epidermal cells as targets. Tamaki K; Fujiwara H; Levy RB; Shearer GM; Katz SI J Invest Dermatol; 1981 Aug; 77(2):225-9. PubMed ID: 7276618 [TBL] [Abstract][Full Text] [Related]
19. Induction of TNP-specific cytotoxic T lymphocyte memory in vivo in the absence of T helper cell activity. Hurme M; Varkila K; Sihvola M J Immunol; 1986 Sep; 137(6):1782-5. PubMed ID: 2943801 [TBL] [Abstract][Full Text] [Related]